In preclinical research, led by Søren P. Sheikh, the promising potential of adipose-derived stem cells has been demonstrated in a rat model for erectile dysfunction.
Therefore, Søren P. Sheikh embarked on a mission to bring stem cell treatment to patients with erectile dysfunction. A disease with a high prevalence and an unmet therapeutic need.
In 2016, the Danish Medicines Agency approved a phase I clinical trial using autologous adipose-derived stem cells to treat erectile dysfunction after prostate cancer surgery.